PRAXIS PRECISION MEDICINES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.26% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-06-30 was 4.26%, a 9.23% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.85%, a 16.12% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-06-30 was 3.90%, a 10.34% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-03-31 was 4.59%, a 18.30% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.45%, a 10.97% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.01%, a 11.39% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.60%.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.47%, a 69.68% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.26% 10-Q · filed 2026-08-06 | 3.87% 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 3.85% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 4.45% 10-K · filed 2026-02-19 | |||
| 2025-09-30 | 4.45% 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 3.90% 10-Q · filed 2025-08-04 | 4.45% 10-Q · filed 2025-08-04 | ||
| 2025-03-31 | 4.59% 10-Q · filed 2025-05-02 | |||
| 2024-12-31 | 4.01% 10-K · filed 2026-02-19 | |||
| 2024-09-30 | 4.06% 10-Q · filed 2024-11-06 | 4.01% 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | 4.35% 10-Q · filed 2024-08-13 | 3.94% 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | 3.88% 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | 3.60% 10-K · filed 2026-02-19 | |||
| 2023-09-30 | 4.35% 10-Q · filed 2023-11-07 | 3.57% 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | 3.84% 10-Q · filed 2023-08-09 | 3.53% 10-Q · filed 2023-08-09 | ||
| 2023-03-31 | 3.51% 10-Q · filed 2023-05-11 | |||
| 2022-09-30 | 2.76% 10-Q · filed 2022-11-09 | 2.50% 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | 3.15% 10-Q · filed 2022-08-08 | 2.50% 10-Q · filed 2022-08-08 | ||
| 2022-03-31 | 1.61% 10-Q · filed 2022-05-09 | |||
| 2021-09-30 | 1.01% 10-Q · filed 2021-11-03 | 0.77% 10-Q · filed 2021-11-03 | ||
| 2021-06-30 | 1.05% 10-Q · filed 2021-08-16 | 0.76% 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | 0.66% 10-Q · filed 2021-05-11 | |||
| 2020-12-31 | 0.47% 10-K · filed 2021-03-17 | |||
| 2019-12-31 | 1.55% 10-K · filed 2021-03-17 | |||
| 2019-09-30 | 1.55% 10-Q · filed 2020-11-23 | 1.55% 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |